David Zaccardelli
2021 - Verona Pharma plc
In 2021, David Zaccardelli earned a total compensation of $1.1M as President and Chief Executive Officer at Verona Pharma plc, a 94% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $328,313 |
|---|---|
| Salary | $272,500 |
| Stock Awards | $496,035 |
| Other | $26,456 |
| Total | $1,123,304 |
Zaccardelli received $496K in stock awards, accounting for 44% of the total pay in 2021.
Zaccardelli also received $328.3K in non-equity incentive plan, $272.5K in salary and $26.5K in other compensation.
Rankings
In 2021, David Zaccardelli's compensation ranked 8,387th out of 12,415 executives tracked by ExecPay. In other words, Zaccardelli earned more than 32.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,387 out of 12,415 | 32nd |
Division Manufacturing | 3,717 out of 5,505 | 33rd |
Major group Chemicals And Allied Products | 1,651 out of 2,375 | 31st |
Industry group Drugs | 1,469 out of 2,096 | 30th |
Industry Pharmaceutical Preparations | 1,094 out of 1,546 | 29th |
Source: SEC filing on March 22, 2022.
Zaccardelli's colleagues
We found three more compensation records of executives who worked with David Zaccardelli at Verona Pharma plc in 2021.